Skip to main content
. 2024 Oct 6;10:88. doi: 10.1038/s41523-024-00697-5

Table 2.

Surgical and Ki67 results

Combo arm (N = 33) Fulv arm (N = 26) Total (N = 59)
Surgerya
 No 2 (6.1%) 1 (3.8%) 3 (5.1%)
 Yes 31 (93.9%) 25 (96.2%) 56 (94.9%)
PEPI Score
 >0 25 (75.8%) 24 (92.3%) 49 (83.1%)
 0 8 (24.2%) 2 (7.7%) 10 (16.9%)
Ki67 at W5b
N 26 24 50
 ≤10% 18 (69.2%) 20 (83.3%) 38 (76.0%)
Ki67 at surgeryb
N 26 22 48
 ≤10% 19 (73.1%) 17 (77.3%) 36 (75.0%)
Change in Ki67 BL—W5
 N 26 22 48
 High BL, High W5 8 (30.8%) 4 (18.2%) 12 (25.0%)
 High BL, Low W5c 11 (42.3%) 9 (40.9%) 20 (41.7%)
 Low BL, Low W5 7 (26.9%) 9 (40.9%) 16 (33.3%)
Change in Ki67 BL—surgery
 N 25 20 45
 High BL, high surgery 7 (28.0%) 4 (20.0%) 11 (24.4%)
 High BL, low surgery 11 (44.0%) 7 (35.0%) 18 (40.0%)
 Low BL, high surgery 0 (0.0%) 1 (5.0%) 1 (2.2%)
 Low BL, low surgery 7 (28.0%) 8 (40.0%) 15 (33.3%)

N is provided for variables with less than 59 variables, and the percentage shown is out of the non-missing total.

a“Yes” indicates patients who had surgery during the study, and “No” indicates patients who did not have surgery during the study. Three patients did not have surgery: one insurance-related, and two received additional therapy prior to surgery due to the physician’s decision.

b“≤10%” indicates patients who had low Ki67 (≤10%) as measured by IHC at each time point. High Ki67 is defined as >10%.

cThe high BL, low W5 group are designated as responders by Ki67.